These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2367614)

  • 1. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder.
    Lopez AL; Kathol RG; Noyes R
    Psychoneuroendocrinology; 1990; 15(1):23-8. PubMed ID: 2367614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agoraphobia and panic disorder: treatment with alprazolam.
    Mark SL
    Tex Med; 1984 Oct; 80(10):50-2. PubMed ID: 6150561
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP; Pecknold JC; Kuch K
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.
    Pecknold JC; Swinson RP
    Psychopharmacol Bull; 1986; 22(1):173-6. PubMed ID: 3726063
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE; Greenberg HS
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
    Sheehan DV; Coleman JH; Greenblatt DJ; Jones KJ; Levine PH; Orsulak PJ; Peterson M; Schildkraut JJ; Uzogara E; Watkins D
    J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepines in panic disorder and agoraphobia.
    Sheehan DV
    J Affect Disord; 1987; 13(2):169-81. PubMed ID: 2890678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazepam and propranolol in panic disorder and agoraphobia.
    Noyes R; Anderson DJ; Clancy J; Crowe RR; Slymen DJ; Ghoneim MM; Hinrichs JV
    Arch Gen Psychiatry; 1984 Mar; 41(3):287-92. PubMed ID: 6367691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W; Noyes R
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder.
    Kathol RG; Anton R; Noyes R; Gehris T
    Biol Psychiatry; 1989 Apr; 25(7):873-8. PubMed ID: 2720002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM; Rubin RT; Rifkin A; Swinson RP; Ballenger JC; Burrows GD; Dupont RL; Noyes R; Pecknold JC
    J Affect Disord; 1989; 16(1):49-58. PubMed ID: 2521651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in hypochondriasis with treatment of panic disorder.
    Noyes R; Reich J; Clancy J; O'Gorman TW
    Br J Psychiatry; 1986 Nov; 149():631-5. PubMed ID: 3814956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia.
    Kathol RG; Noyes R; Lopez AL; Reich JH
    Psychiatry Res; 1988 May; 24(2):211-21. PubMed ID: 3406239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.
    Gastfriend DR; Rosenbaum JF
    Am J Psychiatry; 1989 Jul; 146(7):914-6. PubMed ID: 2568095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonazepam in the treatment of panic disorder and agoraphobia.
    Pollack MH; Rosenbaum JF; Tesar GE; Herman JB; Sachs GS
    Psychopharmacol Bull; 1987; 23(1):141-4. PubMed ID: 3110854
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM; Rubin RT; Pecknold JC; Rifkin A; Swinson RP; Lydiard RB; Burrows GD; Noyes R; DuPont RL
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks.
    Coryell W; Noyes R; Clancy J; Crowe R; Chaudhry D
    Psychiatry Res; 1985 Aug; 15(4):301-11. PubMed ID: 2866558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.